Managing cancer and living meaningfully (CALM): Implementation in Dutch cancer care
- PMID: 38282218
- DOI: 10.1002/pon.6281
Managing cancer and living meaningfully (CALM): Implementation in Dutch cancer care
Abstract
Objective: Managing Cancer and Living Meaningfully (CALM) is a brief, evidence-based psychotherapy tailored for patients with advanced cancer that has not yet been implemented routinely in Dutch cancer care. The aim of this study was to assess the feasibility, acceptability, sustainability and effectiveness of CALM in different clinical settings in the Netherlands.
Methods: In 2019 and 2020 a multi-center, intervention-only study was performed in three Dutch cancer care settings. Professionals were trained to provide CALM under supervision. Patients diagnosed with advanced cancer were included and filled out questionnaires to measure depression (Patient Health Questionnaire-9), death anxiety (Death and Dying Distress Scale), and anxiety (hospital anxiety and depression scale-anxiety) at baseline, 3 and 6 months. The Clinical Evaluation Questionnaire was used to assess acceptability of CALM at 3 and 6 months.
Results: Sixty-four patients (55% of the eligible patients) were included in the study and 85% of the included patients received 3 or more CALM sessions. Of the 24 trained therapists, 15 (63%) started providing CALM. Two years post-study, CALM was provided in each center by a total of 19 therapists. On average, patients perceived CALM to be at least somewhat helpful. A significant decrease in severity of depression (p = 0.006), death anxiety (p = 0.008), and anxiety (p = 0.024) was observed over time.
Conclusions: This study shows that CALM therapy is feasible, acceptable, and sustainable in three Dutch cancer care settings, although not all predefined feasibility criteria for therapists were met. CALM can be effective in decreasing feelings of depression, anxiety, and death anxiety in patients with advanced cancer.
Keywords: anxiety; cancer; depression; oncology; palliative care; psychotherapy.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- Lo C, Zimmermann C, Rydall A, et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol. 2010;28(18):3084-3089. https://doi.org/10.1200/jco.2009.26.9712
-
- Walker J, Holm Hansen C, Martin P, et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013;24(4):895-900. https://doi.org/10.1093/annonc/mds575
-
- Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174. https://doi.org/10.1016/s1470-2045(11)70002-x
-
- Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81-97. https://doi.org/10.1191/0269216302pm507oa
-
- Mehnert A, Vehling S, Hocker A, Lehmann C, Koch U. Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. J Pain Sympt Manag. 2011;42(5):768-776. https://doi.org/10.1016/j.jpainsymman.2011.02.013
MeSH terms
Grants and funding
LinkOut - more resources
Medical
Miscellaneous